Ken Fisher
CLVS

Ken Fisher’s Clovis Oncology, Inc. CLVS Stock Holding History

Ken Fisher’s Portfolio CLVS Stock Details CLVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-15,062
Closed -$106K – 974
2021
Q1 		$106K Sell
15,062
-32,237
-68% -$216K ﹤0.01% 880
2020
Q4 		$227K Buy
47,299
+410
+0.9% +$2.07K ﹤0.01% 849
2020
Q3 		$273K Buy
46,889
+11
+0% +$66 ﹤0.01% 758
2020
Q2 		$316K Buy
46,878
+67
+0.1% +$507 ﹤0.01% 718
2020
Q1 		$298K Sell
46,811
-34,278
-42% -$275K ﹤0.01% 684
2019
Q4 		$845K Sell
81,089
-39,187
-33% -$285K ﹤0.01% 604
2019
Q3 		$473K Hold
120,276
– – ﹤0.01% 696
2019
Q2 		$1.79M Buy
120,276
+60,725
+102% +$1.1M ﹤0.01% 554
2019
Q1 		$1.48M Buy
59,551
+120
+0.2% +$3.01K ﹤0.01% 554
2018
Q4 		$1.07M Hold
59,431
– – ﹤0.01% 589
2018
Q3 		$1.75M Buy
59,431
+1,125
+2% +$43.6K ﹤0.01% 533
2018
Q2 		$2.65M Buy
58,306
+10,345
+22% +$503K ﹤0.01% 506
2018
Q1 		$2.53M Hold
47,961
– – ﹤0.01% 505
2017
Q4 		$3.26M Buy
47,961
+21,328
+80% +$1.49M ﹤0.01% 478
2017
Q3 		$2.19M Buy
+26,633
New +$2.11M ﹤0.01% 490

Other funds holding CLVS

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
IC
Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Ken Fisher's CLVS Position: Q2 2021 in Review

Ken Fisher sold out of Clovis Oncology, Inc. (CLVS) in Q2 2021, closing a stake of 15,062 shares — an estimated $106K sold.

Ken Fisher first reported a position in CLVS in Q3 2017 and held it in 15 quarters. The position peaked at $3.26M in Q4 2017. 160 funds tracked by Wall St. Rank hold CLVS as of Q2 2021.

  • Ken Fisher reported no remaining Clovis Oncology, Inc. position as of Q2 2021 after selling out during the quarter.
  • Ken Fisher sold 15,062 Clovis Oncology, Inc. shares in Q2 2021, an estimated $106K.
  • Ken Fisher first reported a position in Clovis Oncology, Inc. in Q3 2017 and held it in 15 quarters.
  • Ken Fisher's Clovis Oncology, Inc. position peaked at $3.26M in Q4 2017.
  • 160 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q2 2021.

Based on Fisher Asset Management's 13F filing for Q2 2021, filed 27 Jul 2021.